The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1131071
WO Application Number:
SE1999001983
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP99972537.7
WO Publication Number:
WO2000030641
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Sweden (SE)
Publications:
Dates
Filing date:
04/11/1999
Grant date:
14/04/2004
EP Publication Date:
14/04/2004
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/12/2015
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
14/04/2004
EP B1 Publication Date:
14/04/2004
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
03/11/2019
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
10/07/2007
Name:
McNeil AB
Address:
Box 941, SE-251 09, Helsingborg, Sweden (SE)
Historical Applicant/holder
From:
21/03/2007
To:
10/07/2007
Name:
Pfizer Health AB
Address:
Lindhagensgatan 100, SE-112 87, Stockholm, Sweden (SE)
From:
14/04/2004
To:
21/03/2007
Name:
Pharmacia Aktiebolag
Address:
Lindhagensgatan 100, SE-112 87, Stockholm, Sweden (SE)